For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>

API Manufacturer

One of the core business areas of Cadila Pharmaceuticals is to synthesize Active Pharmaceutical Ingredients APIs of the highest standard in an integrated cost effective manner. Spread over 80,000 square meter area, ISO-9001 & ISO14001 API manufacturing facility at Ankleshwar, India is accredited by USFDA, EDQM – European Directorate of Quality Medicine, AIFA – Agenzia Italiana del Farmaco, TGA – Theapeutic Goods Administration, Australia and WHO. The company offers more than 38 APIs and intermediates which are exported across the world. Having filed 29 USDMFs, CEP for 09 APIs and with more in pipeline, the unit is committed to offer an unmatched portfolio.
Therapeutic Category
Search by Product Name
Product Name Therapeutic Category Pharmacopeial Status
Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals